Signal Diagnostics Agrees to Pay over $20M to Settle False Claims Act Allegations for Failing to Refund Overpayments to the HRSA Uninsured Program
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured...
What happened
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured...
Why it matters
The development may change operating conditions or market expectations around Regulation. Further confirmation and measurable outcomes matter.
Affected entities
View evidence
1 reports · 1 original report · 1 independent
- U.S. Department of JusticePrimary source · Supports · EN · 100%Signal Diagnostics Agrees to Pay over $20M to Settle False Claims Act Allegations for Failing to Refund Overpayments to the HRSA Uninsured Program ↗
Claims
- Signal Diagnostics Agrees to Pay over $20M to Settle False Claims Act Allegations for Failing to Refund Overpayments to the HRSA Uninsured Program Observed
Conflicts
No material conflict detected in the available evidence.
Timeline
- First reported
Market move following event
Market reaction is not yet available for this asset and time window.